These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 4085966
1. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA]. Ieko M. Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966 [Abstract] [Full Text] [Related]
2. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis]. Kubicka A, Libura M, Sacha T, Swadźba J, Undas A, Wandzilak M. Pol Tyg Lek; 1985 Nov; 48(5-6):116-9. PubMed ID: 8361905 [Abstract] [Full Text] [Related]
3. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay. Anglés-Cano E, Boutière B, Arnoux D, Masson C, Contant G, Benchimol P, Sampol J. Thromb Haemost; 1987 Oct 28; 58(3):843-9. PubMed ID: 3124285 [Abstract] [Full Text] [Related]
4. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F. Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812 [Abstract] [Full Text] [Related]
5. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis. Declerck PJ, Mombaerts P, Holvoet P, De Mol M, Collen D. Thromb Haemost; 1987 Dec 18; 58(4):1024-9. PubMed ID: 3127914 [Abstract] [Full Text] [Related]
6. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies. Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N. Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090 [Abstract] [Full Text] [Related]
7. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W. Med Sci Monit; 2000 Aug 30; 6(4):684-91. PubMed ID: 11208392 [Abstract] [Full Text] [Related]
8. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N. Thromb Haemost; 1997 Apr 30; 77(4):725-9. PubMed ID: 9134650 [Abstract] [Full Text] [Related]
16. An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Bergsdorf N, Nilsson T, Wallén P. Thromb Haemost; 1983 Oct 31; 50(3):740-4. PubMed ID: 6359572 [Abstract] [Full Text] [Related]
19. Coagulation and fibrinolytic activity in patients with acute cerebral infarction. Li F, Zhang G, Zhao W. Chin Med J (Engl); 2003 Mar 31; 116(3):475-7. PubMed ID: 12781064 [Abstract] [Full Text] [Related]
20. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma. Huisman LG, van Griensven JM, Kluft C. Thromb Haemost; 1995 Mar 31; 73(3):466-71. PubMed ID: 7667830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]